Dow Up0.51% Nasdaq Up0.24%

Alexion Pharmaceuticals, Inc. (ALXN)

-NasdaqGS
191.02 Down 1.53(0.79%) Nov 21, 4:00PM EST
|After Hours : 191.02 0.00 (0.00%) Nov 21, 5:00PM EST
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 1,551,346   1,134,114   783,431  
Cost of Revenue177,556  72,837  93,140  
Gross Profit 1,373,790   1,061,277   690,291  
Operating Expenses
Research Development317,093  222,732  137,421  
Selling General and Administrative489,720  384,678  308,176  
Non Recurring38,550  49,112  13,486  
Others417  417  382  
Total Operating Expenses845,780  656,939  459,465  
Operating Income or Loss 528,010   404,338   230,826  
Income from Continuing Operations
Total Other Income/Expenses Net2,371  630  (370)
Earnings Before Interest And Taxes530,381  404,968  230,456  
Interest Expense4,112  7,402  788  
Income Before Tax526,269  397,566  229,668  
Income Tax Expense273,374  142,744  54,353  
Minority Interest -   -   -  
Net Income From Continuing Ops252,895  254,822  175,315  
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income 252,895   254,822   175,315  
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares 252,895   254,822   175,315  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.